Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
DFCI Obinutuzumab and Ibrutinib Protocol # 15-283
Clinical Trial Grant
Duke Scholars
Principal Investigator
Danielle Marie Brander
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Dana-Farber Cancer Institute
Start Date
November 15, 2017
End Date
December 14, 2022
Awarded By
Dana-Farber Cancer Institute
Start Date
November 15, 2017
End Date
December 14, 2022
